Grants Reporting - Cancer Australia | A national government ... · Web view2017/09/22  · Priority...

87
Grants Reporting The following table details all grants that Cancer Australia has funded since 1 January 2009. Agency Program Title Program Component (if applicable) Recipient Purpose Value Date of Effect Grant Term (months) Grant Funding Location Postcode Cancer Australi a Priority Driven Collaborativ e Cancer Research Scheme Cancer Council Victoria Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A web-based intervention to reduce distress and improve quality of life among younger women with breast cancer: A RCT. App562002. CA-A0809/05 $109,937.18 15/12/2008 53 Carlton 3053 Cancer Australi a Priority- driven Collaborativ e Cancer Research Scheme Queensland Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Towards new screening tests for oesophageal adenocarcinoma Appl ID: 552449 $512,325 01/01/2009 59 Herston QLD 4006 Cancer Australi a Priority Driven Collaborativ e Cancer Research Scheme University of Newcastle Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Targeting p53 isoforms, Δ40p53 and p53β, to promote chemo- sensitivity in human melanoma. App569284. CA- A0809/49 $20,625 04/01/2009 12 Callaghan 2308 Cancer Australi a Priority Driven Collaborativ Queensland Health Priority Driven Collaborative Cancer Research Scheme (PDCCRS) $101,750 13/01/2009 72 Woolloongabba 4102 1 of 87

Transcript of Grants Reporting - Cancer Australia | A national government ... · Web view2017/09/22  · Priority...

Grants Reporting

The following table details all grants that Cancer Australia has funded since 1 January 2009.

Agency

Program Title

Program Component

(if applicable)

Recipient

Purpose

Value

Date of Effect

Grant Term (months)

Grant Funding Location

Postcode

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Cancer Council Victoria

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A web-based intervention to reduce distress and improve quality of life among younger women with breast cancer: A RCT. App562002. CA-A0809/05

$109,937.18

15/12/2008

53

Carlton

3053

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Towards new screening tests for oesophageal adenocarcinoma Appl ID: 552449

$512,325

01/01/2009

59

Herston QLD

4006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Newcastle

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Targeting p53 isoforms, Δ40p53 and p53β, to promote chemo-sensitivity in human melanoma. App569284. CA-A0809/49

$20,625

04/01/2009

12

Callaghan

2308

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Queensland Health

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase II Efficacy Study of Chemo-Radiotherapy in PET Staged II-III Merkel Cell Carcinoma of the Skin. App551200. CA-A0809/06

$101,750

13/01/2009

72

Woolloongabba

4102

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Psychological morbidity, unmet needs, quality of life and patterns of care in migrant cancer patients: The first year. App571009. CA-A0809/37

$20,229.83

14/01/2009

12

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

The University of Wollongong

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: In vivo assessment of small molecule uPA-directed prodrugs for the treatment of malignant disease. App573432. CA-A0809/09

$20,556.25

14/01/2009

25

Wollongong

2522

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of intraprostatic glucocorticoid action in prostate physiology and pathology. App571311. CA-A0809/10

$20,229.83

14/01/2009

12

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Identification of candidate tumour suppressor genes inactivated by promoter methylation in melanoma cell lines. App552466. CA-A0809/25

$20,556.25

20/01/2009

12

Herston

4006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Response to chemotherapy in ovarian cancer. App552481. CA-A0809/22

$625,625

20/01/2009

39

Herston

4006

Cancer Australia

Support for Cancer Clinical Trials Program and Boost Cancer Research Program

 

Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia

Support for Cancer Clinical Trials Program - CA-A0910/16

$311,230.70

27/01/2009

17

University of WA, WA

6009

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Macquarie University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Evaluation of an online decision aid for women with breast cancer considering reconstructive surgery. App543400. CA-A0809/29

$103,803.34

30/01/2009

60

North Ryde

2109

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The Renin Angiotensin System – a Novel Target in the Treatment of Colorectal Liver Metastases. App566536. CA-A0809/47

$20,363.20

30/01/2009

18

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Overcoming chemo-resistance in leukaemia: application of Vorinostat and ABT-737 to a new in vivo model of CLL. App566746. CA-A0809/46

$20,350

30/01/2009

12

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of the kConFab BRCAX cohort for selected breast cancer susceptibility loci and effect on cancer risk. App566791. CA-A0809/44

$527,107.90

30/01/2009

71

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A randomised trial of stereotactic vs conventional radiotherapy for inoperable early stage non-small cell lung cancer. App566813. CA-A0809/45

$286,000

30/01/2009

59

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Methylation in ductal carcinoma in situ. App566882. CA-A0809/43

$294,398.69

30/01/2009

48

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of a tumour-associated PIK3CA mutation using a novel mouse model. App566974. CA-A0809/42

$20,625

30/01/2009

12

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Reversing the debilitating effects of radiotherapy-induced damage in juvenile brain. App566976. CA-A0809/41

$20,625

30/01/2009

12

Parkville

3010

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)

Support for Cancer Clinical Trials Program - CA-A00809/19

$770,880.00

30/01/2009

18

Parkville

3052

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australasian Sarcoma Study Group (ASSG) through University of Melbourne

Support for Cancer Clinical Trials Program - CA-A0809/18

$760,839.20

30/01/2009

18

University of Melbourne, VIC

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Garvan Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: DNA methylation alterations as detection markers for early ovarian cancer. App535957. CA-A0809/28

$639,375

02/02/2009

36

Darlinghurst

2010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of Heat Shock Proteins in the Stromal Reaction of Pancreatic Cancer. App568851. CA-A0809/27

$20,350

02/02/2009

12

Sydney

2052

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Melbourne Health

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Resveratrol in the chemoprevention of colorectal neoplasia. App544307. CA-A0809/39

$633,325

03/02/2009

60

Parkville

3050

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A nurse led psychosocial intervention with peer support to reduce psychosocial needs in women with gynaecological cancer. App566942. CA-A0809/40

$127,930

03/02/2009

24

Parkville

3010

Cancer Australia

Support for Cancer Clinical Trials Program

 

Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0809/17

$364,455.30

03/02/2009

17

University of Sydney, NSW

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Prince Charles Hospital

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Individualising treatment for mesothelioma. App550600. CA-A0809/48

$384,450

04/02/2009

50

Chermside

4032

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Newcastle

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Blood cancer survivors and support persons: A national survey of rural/urban unmet needs and psychological disturbance. App569290. CA-A0809/50

$285,360.90

04/02/2009

52

Callaghan

2308

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study. App570801. CA-A0809/30

$581,916.25

04/02/2009

48

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer. App570860. CA-A0809/31

$211,777.50

04/02/2009

71

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase III study in patients with Locally Advanced Pancreatic cancer: Gemcitabine +/- chemoradiotherapy & +/- erlotinib. App570948. CA-A0809/34

$284,900

04/02/2009

90

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Genome-wide analysis of pre-mRNA splicing regulation by RBM4. App570874. CA-A0809/32

$20,597.50

05/02/2009

12

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Understanding the psychosocial sequelae of surviving testicular cancer. App570961. CA-A0809/35

$104,940

05/02/2009

24

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Short Course Oncology Therapy - A Study of Adjuvant Chemotherapy in Colorectal Cancer by the CACTUS and OCTO Groups. App571314. CA-A0809/38

$329,752.50

05/02/2009

59

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of melanoma stem cells in melanomagenesis. App570778. CA-A0809/21

$20,625

09/02/2009

12

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Southern Queensland

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer (PROFIT – Prostate Fractionated Irradiation Trial). App570403. CA-A0809/20

$487,850

12/02/2009

36

Toowoomba

4350

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0809/52

$839,905.00

18/02/2009

18

University of Sydney, NSW

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Walter and Eliza Hall Institute

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of the GATA-3 transcription factor as a tumour suppressor and potential therapeutic target in breast cancer. App575572. CA-A0809/53

$326,803.95

20/02/2009

36

Parkville

3050

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Faecal microflora and circulating proinflammatory cytokines: key elements to chemotherapy-induced diarrhoea. App553601. CA-A0809/54

$20,625

25/02/2009

12

Adelaide

5005

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Cancer Institute NSW

The continuation of Cancer Service Networks National Demonstration Program (CanNET) in New South Wales

$932,091.60

16/03/2009

56

Alexandria, NSW

1435

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Development of an optimised multidisciplinary intervention for post-cancer fatigue. App568828. CA-A0809/64

$474,650

15/06/2009

61

Sydney

2052

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A combinatorial approach targeting androgen signalling for treatment of prostate cancer. App627229. CA-A0910/87

$321,028.95

01/01/2010

36

Adelaide

5005

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of South Australia

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Development of microfluidic chips to isolate and analyse peripheral blood cell populations in pancreatic cancer patients. App631921. CA-A0910/56

$24,750

06/01/2010

12

Adelaide

5001

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Ludwig Institute of Cancer Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Mechanisms of abiraterone resistance in prostate cancer. App603107. CA-A0910/57

$216,150

18/01/2010

36

Heidelberg

3084

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Garvan Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer. App596858. CA-A0910/54

$213,950

20/01/2010

36

Darlinghurst

2010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Monash University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of the EphA3 receptor in the stromal microenvironment of tumours. App606719. CA-A0910/58

$24,750

20/01/2010

12

Clayton

3168

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Monash University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel monoclonal antibodies for the diagnosis and treatment of epithelial cancers and cancer stem cells. App606552. CA-A0910/55

$94,806.80

21/01/2010

12

Clayton

3168

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Queensland

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: LACE – Laparoscopic Approach to Carcinoma of the Endometrium. An International Multicentre Randomised Phase 3 Clinical Trial. App631523. CA-A0910/46

$643,775

27/01/2010

36

Brisbane

4072

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Lymphocyte receptors that regulate tumor development and therapy. App628304. CA-A0910/49

$24,571.80

29/01/2010

12

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Preventing Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: kConFab Follow-Up Project. App628333. CA-A0910/51

$327,731.25

29/01/2010

36

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identification of BRCAx Genes through targeted next generation sequencing. App628610. CA-A0910/52

$231,000

29/01/2010

36

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Ludwig Institute of Cancer Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: IL-11: A preclinical target for inflammation-associated gastrointestinal cancer. App603121. CA-A0910/45

$24,750

01/02/2010

12

Heidelberg

3084

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of New South Wales

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Too much, too soon? The impact of treatment-focused genetic testing in patients newly diagnosed with breast cancer. App630405. CA-A0910/62

$217,998

09/02/2010

42

Sydney

2052

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Characterization of the immunoregulatory capacity of antibody-based immunotherapeutics in established cancer. App628338. CA-A0910/48

$24,181.58

12/02/2010

12

Parkville

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Curtin University of Technology

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Examination of surgical margins with a positron emission tomography (PET) probe in DCIS and invasive breast cancer. App594409. CA-A0910/64

$41,937.50

17/02/2010

24

Perth

6845

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Trans Tasman Radiation Oncology Group Limited

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Phase II Trial of Integrated Preoperative RT/Chemo with Oxaliplatin, 5-FU and FA in Locally Advanced Rectal Cancer. App626200. CA-A0910/65

$118,250

23/02/2010

40

Waratah

2298

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Newcastle

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Altered nucleotide excision repair in melanoma in response to cisplatin and UV-light irradiation. App631019. CA-A0910/63

$24,750

24/02/2010

15

Callaghan

2308

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer. App632547. CA-A0910/69

$24,750

24/02/2010

12

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Timing of surgery and adjuvant chemotherapy for hepatic metastases from colorectal cancer. App632737. CA-A0910/73

$660,000

24/02/2010

53

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App632740. CA-A0910/75

$209,481.80

24/02/2010

39

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: hOGG1 in human skin carcinogenesis. App632760. CA-A0910/74

$23,443.75

24/02/2010

12

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised trial of consumer-led familial cancer risk tool & GP triage on risk-appropriate colorectal cancer screening. App632887. CA-A0910/70

$537,901.37

24/02/2010

46

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Telomere trimming: a novel mechanism for preventing unlimited cellular proliferation. App633214. CA-A0910/72

$23,443.75

24/02/2010

12

Sydney

2006

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Queensland

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Post-operative enteral nutrition in patients with advanced epithelial ovarian cancer. App631524. CA-A0910/77

$261,910

25/02/2010

36

Brisbane

4072

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Monash University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Pilot of a population-based prostate cancer clinical registry. App606927. CA-A0910/80

$217,387.50

26/02/2010

36

Clayton

3168

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Newcastle

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Control of malignant glioma by naturally occurring oncolytic enteroviruses. App631059. CA-A0910/68

$23,426.70

02/03/2010

12

Callaghan

2308

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

CSIRO

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The effects of microencapsulated butyrylated high amylose maize starch and fish oil on colorectal cancer risk in rats. App593504. CA-A0910/88

$23,153.63

19/03/2010

12

Adelaide

5000

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised controlled trial evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors. App628581. CA-A0910/86

$206,250

29/03/2010

48

Parkville

3010

Cancer Australia

Support for Cancer Clinical Trials Program and Boost Cancer Research Program

 

Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia

Support for Cancer Clinical Trials Program - CA-A0910/126

$1,506,347.70

22/06/2010

36

University of WA, WA

6009

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Trans-Tasman Radiation Oncology Group Limited (TROG)

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised comparison of anastrozole commenced before and continued during adjuvant radiotherapy for breast cancer versus anastrozole and subsequent anti-oestrogen therapy delayed until after radiotherapy ApplID: 626201

$660,000

25/06/2010

48

Newcastle, NSW

2310

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australasian Gastro-Intestinal Trials Group (AGITG) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0910/123

$1,541,030.40

25/06/2010

36

University of Sydney, NSW

2006

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australasian Leukaemia and Lymphoma Group (ALLG)

Support for Cancer Clinical Trials Program - CA-A0910/131

$1,549,296.10

25/06/2010

36

East Melbourne,

3002

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australasian Lung Cancer Trials Group (ALTG) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0910/121

$1,523,481.30

25/06/2010

36

University of Sydney, NSW

2006

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australia and New Zealand Breast Cancer Trials Group (ANZBCTG)

Support for Cancer Clinical Trials Program - CA-A0910/127

$1,541,639.00

25/06/2010

36

Waratah, NSW

2298

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)

Support for Cancer Clinical Trials Program - CA-A0910/129

$1,547,700.00

25/06/2010

36

Royal Melbourne Hospital, VIC

3050

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australia New Zealand Gynaecological Oncology Group (ANZGOG) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0910/122

$1,531,997.50

25/06/2010

36

University of Sydney, NSW

2006

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australia and New Zealand Melanoma Trials Group (ANZMTG) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0910/119

$1,534,589.43

25/06/2010

36

University of Sydney, NSW

2006

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0910/124

$1,534,308.60

25/06/2010

36

University of Sydney, NSW

2006

Cancer Australia

Support for Cancer Clinical Trials Program

 

Australasian Sarcoma Study Group (ASSG) through University of Melbourne

Support for Cancer Clinical Trials Program - CA-A0910/128

$1,536,150.00

25/06/2010

36

University of Melbourne, VIC

3010

Cancer Australia

Support for Cancer Clinical Trials Program

 

Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0910/120

$1,242,144.20

25/06/2010

36

University of Sydney, NSW

2006

Cancer Australia

Support for Cancer Clinical Trials Program

 

Psycho-oncology Co-operative Research Group (PoCoG) through University of Sydney

Support for Cancer Clinical Trials Program - CA-A0910/132

$1,627,835.00

25/06/2010

36

University of Sydney, NSW

2006

Cancer Australia

Support for Cancer Clinical Trials Program

 

TransTasman Radiation Oncology Group (TROG)

Support for Cancer Clinical Trials Program -CA-A0910/125

$1,549,297.20

25/06/2010

36

Waratah, NSW

2287

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Anti - Cancer Foundation of South Australia

Continuing Implementation of the National Cancer Data Strategy

$34,402.50

01/01/2011

3

Eastwood SA

5063

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

2010 PdCCRS: microRNA miR-211 as a novel tumour suppressor for melanoma. App1011300

$49,500.00

21/01/2011

20

Herston QLD

4006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

2010 PdCCRS: Development of a model to classify mismatch repair gene sequence variants of uncertain clinical significance. App1010859

$660,000.00

21/01/2011

48

Herston QLD

4006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Griffith University

2010 PdCCRS: ProsCan for Life: A Multimodal Supportive Care Intervention for Men with Prostate Cancer. App1008320

$329,006.70

24/01/2011

36

Nathan QLD

4111

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Cancer Council QLD

2010 PdCCRS - A multi-level investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer. App1006339

$647,619.50

02/02/2011

36

Fortitude Valley, QLD

4006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

The University of Western Australia

2010 PdCCRS: Endocrine therapies for early breast cancer: health outcomes and policy implications in Australian clinical practice. Targets the National Health Priority Area of Cancer Control, specifically focussing on breast cancer treatment in Australian women. App1011488

$171,048.90

04/02/2011

49

Crawley WA

6009

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

2010 PdCCRS: Identifying markers of risk and outcome in ovarian and breast cancer via efficient of DNA methylation in peripheral blood. App1011143

$191,213.00

08/02/2011

46

Herston QLD

4006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2010 PdCCRS: Genetic and environmental factors in invasive cervical cancer: a twin study. App1008811

$429,458.70

09/02/2011

36

Parkville VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2010 PdCCRS: Fulfilling the vision of youth-friendly cancer care: How well are we meeting the psychosocial needs of AYA patients? App1010977

$164,776.70

09/02/2011

42

Parkville VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Originally University of Melbourne now Ludwig Institute of Cancer Research

2010 PdCCRS: Identifying therapeutic targets by profiling DNA repair in lung cancer CA-A1011/18. App1009892

$552,776.40

09/02/2011

46

Heidelberg VIC

3084

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2010 PdCCRS: Personalised breast cancer risk prediction in BRCA mutation carriers. App1007765

$152,780.10

09/02/2011

63

Parkville VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2010 PdCCRS: Identification of Men with a genetic predisposition to Prostate Cancer: targeted screening in BRCA1/2 mutation carriers and controls - The Impact study. App1006349

$465,329.70

09/02/2011

40

Parkville VIC

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2010: A phase III randomised trial of postmastectomy chest wall irradiation in intermediate risk operable breast cancer. App1004707. CA-A1011/15

$561,000

09/02/2011

36

Parkville

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

The Australian National University

2010 PdCCRS: Targeting of two Aspects of Metabolism (TOTAM) for cancer therapy. App1008861

$546,165.40

14/02/2011

36

Canberra ACT

200

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of New South Wales

2010 PdCCRS: Identification of anti-apoptotic signalling pathways in malignant gliomas. App1010484

$49,500.00

15/02/2011

12

Sydney NSW

2052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of New South Wales

2010 PdCCRS: Role of dietary compounds on PGC-1 alpha methylation in colorectal cancer. App1010361

-

15/02/2011

36

Sydney NSW

2052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of New South Wales

2010 PdCCRS: Targeting drug resistant genes in brain cancer: delivery of siRNA to improve cancer therapy. App1003650

$49,500.00

15/02/2011

19

Sydney NSW

2052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Queensland

Autofluorescence imaging for early detection and surgical margin delineation of oral cancers and pre-cancers. App1009996

$558,131.20

21/02/2011

44

St Lucia, QLD

4072

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

The role of CD123 in MDSA and AML. App1010336

$316,276.40

24/02/2011

36

North Terrace, SA

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2010 PdCCRS: Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial. App1009485

$650,111.00

01/03/2011

60

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2010 PdCCRS: A randomised, placebo-controlled trial of concurrent cediranib [AZD2171] with platinum - based chemotherapy & maintenance cediranib in women with platinum sensitive relapsed ovarian cancer: ICON 6. App1006602

$270,597.80

01/03/2011

24

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2010 PdCCRS: Tumour protein D52 over-expression and DNA repair in cancer. App1007020

$48,132.40

01/03/2011

12

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2010 PdCCRS: START Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer. App1004932

$329,320.20

01/03/2011

38

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Curtin University of Technology

2010 PdCCRS: Meeting the education and support needs of women with breast cancer who are referred for radiotherapy: A multiple - baseline study. App1006458

$220,993.30

01/03/2011

59

Perth, WA

6845

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

2010 PdCCRS: A novel approach to predict metastatic potential of prostate cancer at diagnosis. App1012337

$650,905.20

01/03/2011

36

Adelaide, SA

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2010 PdCCRS: The impact of aberrant progesterone signalling on lineage specification during early malignant transformation. App1009094

$48,129.40

01/03/2011

12

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2010 PdCCRS: Alternative lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test. App1012032

$48,981.90

01/03/2011

12

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2010 PdCCRS: NITRO - A randomised, phase 3 trial of adding nitro-glycerine to first line chemotherapy for advanced non - small cell lung cancer. App1006315

$656,421.70

01/03/2011

36

Sydney, NSW

2006

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Cancer Institute NSW

Maintaining the eviQ Primary Health Care modules

$119,900.00

01/03/2011

16

Australian Technology Park, NSW

2015

Cancer Australia

Improved Cancer Control

Improved Cancer Control

The Australian Lung Foundation

Travel grants for lung cancer nurses to attend the International Lung Cancer Conference in Amsterdam

$22,800.00

29/03/2011

6

Bowen Hills, QLD

4006

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Queensland Health

Cancer care coordination for Indigenous people residing in Far North Queensland

$438,743.80

25/05/2011

18

Brisbane, QLD

4000

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Monash University

2010 PdCCRS: Determining the causes of observed variation in survival after diagnosis of prostate cancer. App1010384

$627,607.20

30/05/2011

36

Clayton, VIC

3800

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Clinical Oncology Society of Australia

Building Cancer Support Networks Initiative - Better Cancer Support through Consumers (BCSN)

$2,970,000.00

02/06/2011

12

Sydney. NSW

2010

Cancer Australia

Data

Improved Cancer Control

Women's and Children's Hospital

For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer

$16,648.50

24/06/2011

5

North Adelaide, SA

5006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

Sequencing the ovarian cancer genome: molecular determinants of tumour growth & treatment failure. App1004673

$660,000.00

30/06/2011

36

Parkville, VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland University of Technology

Skin cancer prevention & early detection for Generation Y. App1011999

$343,776.40

30/06/2011

36

Brisbane, QLD

4001

Cancer Australia

Data

Improved Cancer Control

Austin Health

Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.

$35,255.54

30/06/2011

6

Heidelberg VIC

3084

Cancer Australia

Data

Improved Cancer Control

Prince Charles Hospital

Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.

$18,820.20

30/06/2011

6

Chermside, QLD

4032

Cancer Australia

Data

Improved Cancer Control

Royal Hobart Hospital (Department of Health and Human Services)

Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.

$12,425.24

30/06/2011

6

Hobart, TAS

7000

Cancer Australia

Data

Improved Cancer Control

Nepean Hospital

Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.

$27,056.13

30/06/2011

6

Penrith, NSW

2751

Cancer Australia

Data

Improved Cancer Control

Peter MacCallum Cancer Centre

For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer

$36,960.00

30/06/2011

5

A'Beckett Street, VIC

8006

Cancer Australia

Data

Improved Cancer Control

South Eastern Sydney Local Health District

Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.

$16,376.80

27/07/2011

4

Randwick, NSW

2031

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Breast Cancer Network Australia

For the provision of projects that aim to strengthen support for women with breast cancer

$1,366,200.00

04/11/2011

31

Camberwell, VIC

3124

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 PdCCRS – The role of adjuvant chemotherapy in high-risk endometrial cancer. App1027151

$330,965.80

09/01/2012

47

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 PdCCRS – Phase III trial of Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q non deleted anaplastic glioma - The CATNON Intergroup Trial. App1026842

$217,896.25

09/01/2012

36

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 PdCCRS - Evaluation of a web-based tool for estimating and explaining prognosis in advanced cancer. App1032121

$139,933.75

09/01/2012

48

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 PdCCRS - Evaluation of a psychological and educational intervention for fear of cancer recurrence; A cluster randomised controlled trial. App1022584

$182,124.07

09/01/2012

64

Sydney, NSW

2006

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Breast Cancer Network Australia

Hope and Hurdles Pack

$165,000.00

01/02/2012

5

Camberwell, VIC

3124

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Ludwig Institute for Cancer Research

2011 PdCCRS - Discovery of colorectal cancer subtype associated tumour suppressor genes using next-generation sequencing and high throughput functional genomics. App1030098

$482,476.50

02/02/2012

36

Heidelberg, VIC

3084

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Edith Cowan University

2011 PdCCRS - Can exercise ameliorate treatment toxicity during the initial phase of testosterone suppression in prostate patients? Is this more effective than delayed rehabilitation and what is the time course and persistence of benefits? App1029901

$163,634.45

02/02/2012

46

Joondalup, WA

6027

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of New South Wales

2011 - PdCCRS 'ReCaPTure LiFe': A phase 11 randomised trial of a psychological intervention to support adolescent and young adult cancer survivors. App1022868

$148,811.45

17/02/2012

36

Sydney, NSW

2052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Garvan Institute of Medical Research

2011 - PdCCRS - The role of p53-regulated microRNAs in epithelial to mesenchymal transition, and their potential as therapeutic targets against metastatic breast cancer. App1034561

$24,750.00

17/02/2012

12

Sydney. NSW

2010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Menzies Research Institute

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Integrative genomic approaches to understanding the genetics of prostate cancer. App ID: 544938; Ref: CA-A0809/11

$567,270

17/02/2012

68

Hobart, TAS

7000

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Wollongong

2011 - PdCCRS -Quantifying the impact of imaging choice for breast cancer radiotherapy. App1033237

$143,585.20

21/02/2012

41

Wollongong, NSW

2522

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

The State of Queensland through Queensland Health via The Princess Alexandra Hospital Metro South District

2011 - PdCCRS - A randomised Phase III trial of High Dose Palliative Radiotherapy (HDPRT) versus concurrent Chemotherapy and HDPRT (C-HDPRT) in patients with Good performance Status. Locally Advanced/Small Volume Metastatic Non-small Cell Lung Cancer not suitable for Radical Chemo-therapy. App1030265

$327,214.80

21/02/2012

72

Woolloongabba, QLD

4102

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Western Australia

2011 - PdCCRS - The initiation of the cellular immune response to cutaneous melanoma. App1034730

$24,750.00

21/02/2012

12

Heidelberg, VIC

3084

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 - PdCCRS - Inhibition of Glioblastoma Invasion by Novel Dynamin Ring Stabilisers. App1021331

$24,399.38

21/02/2012

12

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 - PdCCRS - Mechanism of 133p53 isoform oncogenicity. App1030408

$24,399.38

21/02/2012

12

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 - PdCCRS - Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial. App1029819

$220,000.00

21/02/2012

71

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 - PdCCRS - The role of Single Stranded DNA Binding Proteins in the Alternative Lengthening of Telomeres mechanism. App1030040

$48,798.75

21/02/2012

24

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2011 - PdCCRS - The use of RNAi to identify new therapeutic targets for malignant mesothelioma. App1031821

$411,650.80

21/02/2012

36

Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2011 PdCCRS - Targeting dormancy in metastatic breast cancer. App1020272

$148,179.90

23/02/2012

36

Melbourne, VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2011 PdCCRS - Defining the hereditary contribution to ovarian cancer: The role of mismatch repair genes. App1024096

$614,090.40

23/02/2012

41

Melbourne, VIC

3010

Cancer Australia

Improved Cancer Control

Improved Cancer Control

Breast Cancer Network Australia

My Journey Kit

$248,600.00

23/02/2012

6

Camberwell, VIC

3124

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of New South Wales

2011 - PdCCRS - Thromboembolism in Cancer. App1026790

$24,750.00

20/03/2012

20

Sydney, NSW

2052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2011 - PdCCRS - Determining Predictors of Sensitivity to Chk Inhibitors in Metastatic Melanoma. App1029585

$651,585.00

20/03/2012

46

Melbourne , VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

2011 - PdCCRS - Salinomycin a potential glioma stem cell targeting therapy. App1031303

$240,862.50

20/03/2012

12

Brisbane, QLD

4006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

2011 - PdCCRS - Androgen receptor action in the prostate cancer microenvironment. App1032970

$316,571.20

20/03/2012

43

Adelaide, SA

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

2011 - PdCCRS - Reactivating the p53 pathway as a novel therapeutic approach to cancer treatment. App1034715

$49,500.00

20/03/2012

24

Adelaide, SA

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2011 - A novel method to detect and characterise dysplasia and early cancer in Barrett's oesophagus. Appl ID: 1031971

$24,750

20/03/2012

24

Adelaide, SA

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2011: Is elevated N-cadherin expression a poor prognostic indicator in multiple myeloma patients. Appl ID: 1030518

$290,766.30

20/03/2012

48

Adelaide, SA

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Newcastle

2011 - PdCCRS - The therapeutic potential of targeting S100A2 calcium-binding protein in pancreatic cancer. App1033781

$44,362.50

03/04/2012

27

Callaghan, NSW

2308

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Cancer Council South Australia

Supporting people with Cancer grant initiative

$85,800.00

12/06/2012

24

Eastwood, SA

5063

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

The Prince Charles Hospital

Supporting people with Cancer grant initiative

$88,000.00

12/06/2012

30

Brisbane, QLD

4032

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Paediatric Integrated Cancer Service

Supporting people with Cancer grant initiative. CA-A1112/42

$86,361.00

12/06/2012

25

Parkville, VIC

3056

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Australian Lung Foundation

Supporting people with Cancer grant initiative

$83,050.00

12/06/2012

24

Bowen Hills, QLD

4006

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

BreaCan

Supporting people with Cancer grant initiative

$88,000.00

12/06/2012

24

Melbourne, VIC

3000

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Cancer Council VIC

Supporting people with Cancer grant initiative

$86,460.00

12/06/2012

24

Carlton, VIC

3053

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

CanRevive

Supporting people with Cancer grant initiative

$87,934.00

25/06/2012

24

Sydney, NSW

2000

Cancer Australia

Improved Cancer Control

Improved Cancer Control

The Medical Oncology Group of Australia

To support the attendance at the ACORD Workshop of four (4) early career oncology clinical researchers from Australia selected as participants and the attendance as a faculty member of the Cancer Australia Chair in Quality of Life Research.

$24,750.00

26/06/2012

1

Sydney, NSW

2000

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Cancer Voices Victoria

Supporting people with Cancer grant initiative

$84,392.00

27/06/2012

24

Carlton, VIC

3053

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Australian Cancer Survivorship

Supporting people with Cancer grant initiative

$88,000.00

28/06/2012

25

East Melbourne, VIC

3002

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Cancer Council NSW

Supporting people with Cancer grant initiative

$88,000.00

28/06/2012

25

Woolloomooloo, NSW

2011

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

University of South Australia

Supporting people with Cancer grant initiative

$82,500.00

28/06/2012

24

Adelaide, SA

5000

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Menzies School of Health and Research

Supporting people with Cancer grant initiative

$87,774.00

29/06/2012

24

Spring Hill, QLD

4000

Cancer Australia

Supporting People with Cancer Grant initiative

Improved Cancer Control

Cancer Council TAS

Supporting people with Cancer grant initiative

$16,702.40

29/06/2012

24

Hobart, TAS

7000

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Wellington Aboriginal Corporation

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,260

03/10/2012

3

Wellington, NSW

2820

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Top End Remote Health Branch

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,500

03/10/2012

3

Winnellie, NT

822

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

South Coast Medical Service Aboriginal Corporation

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,490

03/10/2012

3

Nowra, NSW

2541

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Napranum Primary Health Care Clinic

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$1,850

03/10/2012

3

Wiepa, QLD

4874

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Kalwun Development Corporation Limited

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,500

03/10/2012

3

Miami, QLD

4220

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Inala Community Health Centre

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$1,600

03/10/2012

3

Inala, QLD

4077

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Illawarra Womens Health Centre

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,500

03/10/2012

3

Warilla, NSW

2528

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Goulburn Valley Health

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,600

03/10/2012

3

Wodonga, VIC

3689

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Western NSW Local Health District, Dubbo Community Health Centre

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$4,000

03/10/2012

3

Dubbo, NSW

2830

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Dareton Primary Health Centre

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$1,500

03/10/2012

3

Dareton, NSW

2717

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Bulgarr Ngaru Medical Aboriginal Corporation

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$4,000

03/10/2012

3

Grafton, NSW

1256

Cancer Australia

Aboriginal and Torres Strait Islander Registered Training Organisation Grants

 

Indigenous Wellbeing Centre Ltd

To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.

$11,000

26/10/2012

7.5

Bundaberg QLD

4670

Cancer Australia

Aboriginal and Torres Strait Islander Registered Training Organisation Grants

 

QLD Aboriginal and Torres Strait Islander Health Worker Education Program Aboriginal Corporation

To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.

$11,000

26/10/2012

7.5

Cairns, QLD

4870

Cancer Australia

Aboriginal and Torres Strait Islander Registered Training Organisation Grants

 

Central Australian Remote Health Development Services Ltd

To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers

$11,000

28/11/2012

7

Alice Springs

870

Cancer Australia

Aboriginal and Torres Strait Islander Registered Training Organisation Grants

 

Kimberley Aboriginal Medical Services Council Inc

To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.

$11,000

28/11/2012

6

Broome

6725

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

Cancer Council Queensland

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Improving the Psychosocial Health of People with Cancer and their Carers: A Community-Based Approach. App561701. CA-A0809/07

$297,156.20

13/01/2013

47

Fortitude Valley

4006

Cancer Australia

Ralph Lauren Pink Pony 12-13

 

 

Ralph Lauren Pink Pony Campaign Scholarships

$17,500

14/02/2013

10

Various

Various

Cancer Australia

Improved Cancer Control

 

Southern Adelaide Local Area Health Network: Repatriation General Hospital

Prostate Cancer Data Set Specification Pilot Project

$19,121.81

25/02/2013

5

Daws Park

5041

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

Improved Cancer Control

Murrumbidgee Medicare Local

For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities

$2,800

28/02/2013

5

Tumut, NSW

2720

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: High Risk genes for Lobular Breast Cancer. Appl ID 1047347.

$100,000

01/03/2013

36

Parkville

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Technology Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Molecular characterisation of a novel target in multiple myeloma. Appl ID 1050067.

$23,745.25

01/03/2013

15

Broadway

2007

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

The Australian National University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Equivalence of sun exposure and vitamin D supplementation in vitamin D insufficiency. Appl ID 1045198

$582,911

01/03/2013

58

Acton

200

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Walter and Eliza Hall Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Innate immune cell protection and colon cancer. Appl ID 1050241

$26,826.53

01/03/2013

12

Parkville

3052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: PETACC-6: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. Appl ID 1048035

$123,331

04/03/2013

49

The University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Off The Shelf T-cells Expressing a Non-MHC Restricted CD19 Specific Chimeric Antigen Receptor for use in a Phase I Study of T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454

$47,500

04/03/2013

37

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the mechanism of action of the cancer-associated enzyme telomerase using disease linked telomerase mutants. Appl ID 1048376

$24,972.75

04/03/2013

12

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The cost-effectiveness of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modelled economic evaluation. Appl ID 1046923

$184,475

04/03/2013

36

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: ICON8: An international multi-stage randomised phase III trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy for women with newly diagnosed epithelial ovarian cancer. Appl ID 1044344

$257,241

04/03/2013

36

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The Use and Impact of High Cost Targeted Cancer Medicines: Theory and Reality. Appl ID 1050648

$133,002

04/03/2013

46

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of New South Wales

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Testing of biomarkers of human papillomavirus on anal cytology in homosexual men to predict the presence of high-grade anal intraepithelial neoplasia and its progression and persistence. Appl ID 1043299

$48,137.50

11/03/2013

32

Kensington

2232

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2009 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Translation of clinical and functional imaging data to brachytherapy treatment optimisation for prostate cancer ApplID: 628592

$86,395.83

27/03/2013

48

Parkville VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

2008 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Improving Outcomes for Women with Endometrial Cancer: Follow-up, survival and quality of life ApplID: 552468

$656,466.80

27/03/2013

60

Herston QLD

4006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Monash University

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Defining Epigenetic Changes in Prostate Cancer Stroma. Appl ID 1044458

$597,987

31/03/2013

36

Clayton

3800

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Garvan Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Characterising a new mode of regulation of the beta-catenin pathway in colorectal cancer. Appl ID 1049846.

$49,945.50

01/04/2013

24

Darlinghurst

2010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mechanism and targeting of castration-resistant prostate cancer. Appl ID 1043482.

$270,569

01/04/2013

36

Adelaide

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Targeting the androgen receptor in triple negative breast cancer. Appl ID 1043497.

$196,474.70

01/04/2013

36

Adelaide

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the tumour-promoting phenotype of cancer-associated fibroblasts in serous epithelial ovarian cancer. Appl ID 1050101

$24,640.25

01/04/2013

20

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland University of Technology

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mirena ± Weight Loss to treat early Endometrial Cancer: (MAxWEL Trial). Appl ID 1044900

$600,000

01/04/2013

36

Kelvin Grove

4059

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Preferences for adjuvant chemotherapy in early non-small-cell lung cancer: what makes it worthwhile?: ApplID: 570905

$316,167.50

09/04/2013

59

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Genomic determinants of chemosensitivity in ovarian cancer ApplID: 632595

$604,725

09/04/2013

39

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel MicroRNA regulators in the Breast Cancer EMT ApplID: 628720

$281,620.90

18/04/2013

46

Parkville VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Adelaide

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A pharmacodynamic study of the heat shock protein 90 (Hsp90) inhibitor, AUY922, in high-risk, localised prostate cancer. Appl ID 1050880.

$360,977

01/05/2013

59

Adelaide

5005

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Randomised phase III study of preop-chemoradiotherapy versus preop-chemotherapy for resectable gastric cancer: Appl ID: 570996

$595,301.66

07/05/2013

72

University of Sydney

2006

Cancer Australia

Improved Cancer Control

 

Anti-Cancer Council of Victoria

Capturing information on clinical stage, metastases at diagnosis and cancer recurrence employing IT solutions

$1,647,499

07/05/2013

42

Carlton, VIC

3053

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The use and impact of cancer medicines in real world clinical practice: Evaluation in a cohort of elderly Australians. Appl ID: 568773

$459,525

23/05/2013

59

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Peter MacCallum Cancer Centre

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised phase III trial to assess response adapted therapy using PET in newly diagnosed advanced Hodgkin Lymphoma. Appl ID: 628842

$124,666.67

23/05/2013

42

Peter MacCallum Cancer Centre

3002

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: RNA Loading of Tumour Associated Antigens and the Activation of Blood Dendritic Cells for Prostate Cancer Immunotherapy: Appl ID: 543713

$327,195

23/05/2013

74

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Solving Unknown Primary cancER – SUPER. Appl ID 1048193.

$599,381

01/06/2013

61

Parkville

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours: An Australian-Led, International Randomised Trial. Appl ID 1041733

$252,583.48

01/06/2013

50

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Adding mitomycin C to intravesical BCG for high-risk, non-muscle-invasive bladder cancer: a randomised phase 3 trial. Appl ID 1041651

$457,143.17

01/06/2013

58

University of Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Germline Copy Number Variants are Genetic Risk Factors for Familial Colorectal Cancer. Appl ID 1052035

$24,420.50

01/06/2013

19

Herston

4028

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: RAD51 overexpression regulates pro-metastatic gene expression profiles of aggressive metastatic triple negative breast cancer. Appl ID 1050903

$24,764

01/06/2013

12

Herston

4028

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A Phase II study to evaluate the safety and potential benefit of intraperitoneal (IP) bevacizumab to control symptomatic malignant ascites in patients with chemotherapy resistant ovarian cancers: REZOLVE (ANZGOG-1101). Appl ID 1050134

$277,958

28/06/2013

36

The University of Sydney, NSW

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Identification of novel permissive mutations representing acquired vulnerabilities in lung cancer - CA-A1314/20 ApplID: 1070515

$50,000

04/02/2014

47

Herston, QLD

4028

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Walter and Eliza Hall Institute of Medical Research

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Regulating BAK and BAX conversion to death-inducing oligomers. App1069567 - CA-A1314/18

$27,500

15/02/2014

12

Parkville, VIC

3052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Garvan Institute of Medical Research

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): From functional genomics to precision medicine: The therapeutic potential of targeting Rho/ROCK signalling in pancreatic cancer. App1065022 - CA-A1314/04

$599,997

17/02/2014

36

Darlinghurst, NSW

2010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Princess Alexandra Hospital

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A Randomised Trial of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck. App1060687 Ref: CA1314-12

$335,000

20/02/2014

48

Woolloongabba, Qld

4102

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland Institute of Medical Research

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Understanding DNA integrity and telomerase in acute myeloid leukaemia stem cell function. App 1059292: CA-A1314/17

$25,000

27/02/2014

12

Herston, QLD

4028

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Ludwig Institute for Cancer Research

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Targeting the dimerisation arm of EGFR- biological effects and therapeutic implications. App 1063413: CA-A1314/23

$28,167.98

27/02/2014

24

Heidelberg, VIC

3084

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of NSW

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: A multicentre phase II randomised controlled trial of a parent/carer-targeted intervention to improve quality of life in families of young cancer survivors. ID 1065428. CA-A1314/02

$457,353

27/02/2014

48

Kensington

2052

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Maximising benefits and minimising harms in the BreastScreen program: a population health economics modelling approach. App 1066771: CA-A1314/06

$593,893

05/03/2014

48

Parkville, VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland University of Technology

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Mimicking the HSC niche and enabling HSC self-renewal in vitro. App1060928: CA-A1314/21

$50,000

05/03/2014

24

Kelvin Grove, QLD

4059

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Queensland University of Technology

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): miRSNPs as novel diagnostic and prognostic biomarkers for prostate cancer. App 1068321: CA-A1314/22

$50,000

05/03/2014

24

Kelvin Grove, QLD

4059

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ECHO trial: Exercise during CHemotherapy for Ovarian cancer. ID 1063509

$300,000

18/03/2014

36

Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and controls – The IMPACT study. App 1059423: CA-A1314/01

$292,151

21/03/2014

44

Parkville, VIC

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Quantifying genetic risk in sarcoma and translation into health outcomes. ID1067094. CA-A1314/09

$597,793

21/03/2014

36

University of Melbourne

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Melbourne

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Novel Therapies to Treat Brain Metastatic Breast Cancer. ID 1067045. CA-A1314/10

$398,447

28/03/2014

36

University of Melbourne

3010

Cancer Australia

Priority Driven Collaborative Cancer Research Scheme

 

University of Sydney

Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial. ID1068044. CA-A1314/08

$276,811.50

28/03/2014

36

Sydney

2006

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Monash University

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Nuclear receptors and their functions in breast cancer stroma: identification of novel therapeutic targets. App 1058516: CA-A1314/19

$49,518.50

01/04/2014

24

Clayton, VIC

3800

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Investigation of molecular imaging and serum biomarkers to identify lung injury and enable individualised radiation therapy for lung cancers. App1060919

$498,012

01/04/2014

49

Parkville, VIC

3010

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

Monash University

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): An inhalable dendrimer-based delivery platform for the targeted treatment of primary and secondary lung cancers. App 1070184: CA-A1314/11

$452,383

23/04/2014

36

Clayton, VIC

3800

Cancer Australia

Supporting People with Cancer Grant initiative

 

Paediatric Integrated Cancer Service

Supporting people with Cancer grant initiative

$86,361.00

16/05/2014

25

Parkville VIC

3052

Cancer Australia

Supporting People with Cancer Grant initiative

 

The Prince Charles Hospital

Supporting people with Cancer grant initiative

$88,000.00

16/05/2014

30

Brisbane, QLD

4032

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Sydney

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App 1063014: CA-A1314/69

$546,676

20/05/2014

36

The University of Sydney, NSW

2006

Cancer Australia

Jeannie Ferris Cancer Australia Recognition Award 2014

 

Various

To recognise outstanding contribution in gynaecological cancer through the Jeannie Ferris Cancer Australia Recognition Award

$4,000

26/05/2014

NA

 

 

Cancer Australia

Priority-driven Collaborative Cancer Research Scheme

 

University of Melbourne

2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A randomised trial of stereotactic radiotherapy versus conventional radiotherapy for stage I non-small cell lung cancer. App1060822 Ref: CA-1314/14

$320,000

01/06/2014

43

Parkville, VIC

3010

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

 

Arts out West Inc

To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/04

$2,200

05/06/2014

3

Bathurst, NSW

2795

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

 

Cancer Council NT Inc

To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/06

$4,400

05/06/2014

3

Casuarina, NT

810

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

 

Central and North West Queensland Medicare Local

To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/07

$3,993

05/06/2014

3

Normanton QLD

4890

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

 

Country Health SA Local Health Network Inc

To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/08

$3,000

05/06/2014

3

 

 

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

 

Hume Regional Integrated Cancer Service

To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/09

$3,410

05/06/2014

3

Shepparton, VIC

3630

Cancer Australia

Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative

 

Institute for Urban Indigenous Health

To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/11